← Leaderboards
Peter C Lucas
University Of Michigan At Ann Arbor
$14,854,904
Attributed
$32,888,916
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$32,888,916 · 9
By mechanism
U24$21,973,835 · 1
R01$8,557,869 · 4
U10$991,914 · 1
K08$684,500 · 1
P50$600,501 · 1
F32$80,297 · 1
Top collaborators
- Linda M Mcallister-Lucas13 shared
- Richard C Jordan9 shared
- Nilsa Del Carmen Ramirez9 shared
- Christine H Chung2 shared
- Matthew J Ellis2 shared
- Jingqin Luo2 shared
- David G Mutch2 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Linda M McAllister-Lucas$4,836,096
- Gabriel Nunez$34,455,724
- Thomas G Brock$2,351,994
- Jay Luther$39,855
- Wilhelm Salmen$80,224
Others in their field
Top investigators on “Link”
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- David R. Weir · University Of Michigan At Ann Arbor$206,261,870
- Clare E Reimers · Gordon Research Conferences$205,233,456
- Demian A Bailey · Oregon State University$205,233,456
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Greg Ulses · Consortium For Ocean Leadership, Inc$140,113,248
Research focus
LinkMolecularSignal TransductionProteinsDesignInnovationMediatingMalignant NeoplasmsPathway InteractionsSpecimenSignal PathwayIn VivoTranscription FactorResponseComplexLeadEventSiteSignaling ProteinAngiotensin IiReceptorBiochemicalIn VitroPrevent
Grant awards (45)
Role of MALT1 in regulating the breast cancer immune microenvironment$539,078
R01 · FY2025 · CA · contact PI
Project 4$267,959
P50 · FY2025 · CA · contact PI
Project 4$332,542
P50 · FY2024 · CA · contact PI
Role of MALT1 in regulating the breast cancer immune microenvironment$339,519
R01 · FY2023 · CA · contact PI
Role of MALT1 in regulating the breast cancer immune microenvironment$187,132
R01 · FY2023 · CA · contact PI
NRG Oncology Biospecimen Bank$4,229,778
U24 · FY2022 · CA
New mechanisms for modulating the MALT1 oncoprotein$368,587
R01 · FY2022 · CA
NRG Oncology Biospecimen Bank$4,219,090
U24 · FY2021 · CA
New mechanisms for modulating the MALT1 oncoprotein$376,110
R01 · FY2021 · CA
NRG Oncology Biospecimen Bank$2,541,085
U24 · FY2020 · CA
NRG Oncology Biospecimen Bank$865,475
U24 · FY2020 · CA
New mechanisms for modulating the MALT1 oncoprotein$475,758
R01 · FY2020 · CA
NRG Oncology Biospecimen Bank$3,037,138
U24 · FY2019 · CA
New mechanisms for modulating the MALT1 oncoprotein$463,367
R01 · FY2019 · CA
NRG Oncology Biospecimen Bank$2,158,763
U24 · FY2018 · CA
NRG Oncology Biospecimen Bank$600,000
U24 · FY2018 · CA
New mechanisms for modulating the MALT1 oncoprotein$536,920
R01 · FY2018 · CA
Integrated Translational Genoproteomics Center at Washington University$451,509
U10 · FY2018 · CA
NRG Oncology Biospecimen Bank$2,132,946
U24 · FY2017 · CA
Integrated Translational Genoproteomics Center at Washington University$540,405
U10 · FY2017 · CA
GPCR Signaling Through a Novel NF-kB Pathway$385,000
R01 · FY2017 · HL · contact PI
NRG Oncology Biospecimen Bank$2,189,560
U24 · FY2016 · CA
GPCR Signaling Through a Novel NF-kB Pathway$385,000
R01 · FY2016 · HL · contact PI
GPCR Signaling Through a Novel NF-kB Pathway$379,225
R01 · FY2015 · HL · contact PI
GPCR Signaling Through a Novel NF-kB Pathway$365,569
R01 · FY2014 · HL · contact PI
GPCR Signaling Through a Novel NF-kB Pathway$381,250
R01 · FY2013 · HL · contact PI
Novel signal pathway mediating Hypertension/Obesity-dependent Insulin Resistance$307,487
R01 · FY2013 · DK · contact PI
Novel signal pathway mediating Hypertension/Obesity-dependent Insulin Resistance$239,913
R01 · FY2012 · DK · contact PI
Angiotensin II Signaling Through A Novel NF-kB Pathway$203,279
R01 · FY2012 · HL · contact PI
Angiotensin II Signaling Through A Novel NF-kB Pathway$145,965
R01 · FY2012 · HL · contact PI
Novel signal pathway mediating Hypertension/Obesity-dependent Insulin Resistance$69,097
R01 · FY2012 · DK · contact PI
Angiotensin II Signaling Through A Novel NF-kB Pathway$352,772
R01 · FY2011 · HL · contact PI
Novel signal pathway mediating Hypertension/Obesity-dependent Insulin Resistance$312,156
R01 · FY2011 · DK · contact PI
Angiotensin II Signaling Through A Novel NF-kB Pathway$352,772
R01 · FY2010 · HL · contact PI
A Novel Signaling Pathway Mediating Hypertension- and Obesity-dependent Insulin R$347,927
R01 · FY2010 · DK · contact PI
Angiotensin II Signaling Through A Novel NF-kB Pathway$352,772
R01 · FY2009 · HL · contact PI
A Novel Signaling Pathway Mediating Hypertension- and Obesity-dependent Insulin R$351,442
R01 · FY2009 · DK · contact PI
Angiotensin II Signaling Through A Novel NF-kB Pathway$339,772
R01 · FY2008 · HL · contact PI
NF-kB Signaling & Molec Pathogenesis of MALT Lymphoma$136,900
K08 · FY2006 · CA · contact PI
NF-kB Signaling &Molec Pathogenesis of MALT Lymphoma$136,900
K08 · FY2005 · CA
NF-kB Signaling &Molec Pathogenesis of MALT Lymphoma$136,900
K08 · FY2004 · CA
NF-kB Signaling &Molec Pathogenesis of MALT Lymphoma$136,900
K08 · FY2003 · CA
NF-kB Signaling &Molec Pathogenesis of MALT Lymphoma$136,900
K08 · FY2002 · CA
CIPER--A NOVEL APOPTOSIS REGULATOR INVOLVED IN CANCER$33,997
F32 · FY2002 · CA
CIPER--A NOVEL APOPTOSIS REGULATOR INVOLVED IN CANCER$46,300
F32 · FY2000 · CA